News
13 Mar 2019
BIOINTAXIS - A NEW COMPANY DEDICATED TO THE INVESTIGATION OF RARE DISEASES
Originally a foundation at the Institut d’Investigació en Ciències de la salut Germans Trias i Pujol (IGTP), Biointaxis has been created for the investigation of rare diseases and especially of Friedrich's Ataxia.
In December 2018 the project successfully completed the pre-clinical phase where ataxia and the clinical signs were corrected with the transfer of frataxin protein to a mouse model with the disease, through the use of a vector based on adeno-associated virus (AAV), to the damaged neurons that are located mainly in the spinal cord and cerebellum. Our research is now being transferred in the design of a clinical trial for patients with Friedreich's Ataxia.
Mentioned Companies
Gentec S.A.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance